- Advances in the development of anti-cancer vaccines2018 | Second Faculty of Medicine
- Mitochondrial complex II, a novel target for anti-cancer agents2013 | Central Library of Charles University
- Potential Anti-cancer Drugs Commonly Used for Other Indications2015 | Faculty of Pharmacy in Hradec Králové, Faculty of Medicine in Hradec Králové
- LC-MS/MS identification of the principal in vitro and in vivo phase I metabolites of the novel thiosemicarbazone anti-cancer drug, Bp4eT2012 | Faculty of Pharmacy in Hradec Králové
- Exploring the Anti-Cancer Activity of Novel Thiosemicarbazones Generated through the Combination of Retro-Fragments: Dissection of Critical Structure-Activity Relationships2014 | Faculty of Pharmacy in Hradec Králové
- Perspectives of anti-cancer therapy2001 | First Faculty of Medicine
- Mitochondrial targeting of vitamin E succinate enhances its pro-apoptotic and anti-cancer activity via mitochondrial complex II2011 | Central Library of Charles University
- Simultaneous determination of the novel thiosemicarbazone anti-cancer agent, Bp4eT, and its main phase I metabolites in plasma: Application to a pilot pharmacokinetic study in rats2014 | Faculty of Pharmacy in Hradec Králové
- Evaluation of Anti-cancer Therapies with Reimbursement Limited to Comprehensive Cancer Centres Using the European Society for Medical Oncology Magnitude of Clinical Benefit Scale2017 | First Faculty of Medicine, Faculty of Medicine in Pilsen
- Ribonucleases /RNases/ in anti-cancer treatment2005 | First Faculty of Medicine, Second Faculty of Medicine
- Targeted anti-cancer drugsPublication without faculty affiliation
- Novel SPME fibers based on a plastic support for determination of plasma protein binding of thiosemicarbazone metal chelators: a case example of DpC, an anti-cancer drug that entered clinical trials2019 | Faculty of Pharmacy in Hradec Králové
- Pharmacokinetic guided anti-cancer treatmentPublication without faculty affiliation
- Molecular mechanisms of anti-cancer treatment resistance in prostate tumours2014 | Faculty of Science, Second Faculty of Medicine
- Molecularly-Targeted and Biological Anti-Cancer Therapy2012 | First Faculty of Medicine
- Anti-cancer immunity and new strategies to cancer treatment2005 | First Faculty of Medicine
- Cardiotoxicity of anti-cancer drugs in experimental settings2017 | Faculty of Medicine in Hradec Králové
- Development of HPLC methods for purity and stability evaluation of potential anti-cancer agentsPublication without faculty affiliation
- Colorectal carcinoma: Importance of colonic environment for anti-cancer response and systemic immunity2009 | First Faculty of Medicine
- Phase II biotransformation enzymes involved in phase I biotransformation of the anti-cancer drug oracin in manPublication without faculty affiliation
- Application of proteomics in the search for novel proteins associated with the anti-cancer effect of the synthetic cyclin-dependent kinase inhibitor, bohemine2002 | Faculty of Science
- Application of proteomics in the search for novel proteins associated with the anti-cancer effect of the synthetic cyclin-dependent kinase inhibitor, bohemine2002 | First Faculty of Medicine, Faculty of Mathematics and Physics
- Anti-cancer organoruthenium(II) complexes and their interactions with cysteine and its analogues. A mass-spectrometric study2019 | Faculty of Science
- Monitoring of the side effects of anti-cancer therapy using cardio-specific enzymes2006 | Faculty of Medicine in Pilsen
- Characterisation of Mesothelioma-initiating cells and their susceptibility to anti-cancer agents2015 | Publication without faculty affiliation
- Determination of anti-cancer drug emodin using a silica-gel-modified carbon paste electrode2014 | Publication without faculty affiliation
- In Vitro Characterization of the Pharmacological Properties of the Anti-Cancer Chelator, Bp4eT, and Its Phase I Metabolites2015 | Faculty of Pharmacy in Hradec Králové
- Establishment of systemic anti-cancer immunity in mice after the treatment with polymer-bound doxorubicinPublication without faculty affiliation
- Immunomodulating anti-cancer chemotherapy based on HPMA conjugates with pH-controlled release of doxorubicinPublication without faculty affiliation
- Synthetic cyclin-dependent kinase inhibitors. New generation of potent anti-cancer drugs.1999 | Faculty of Physical Education and Sport